Oncotarget can be considered as being a primary source of learning for anybody. The website has been made to specifically enable people to take advantage of an opportunity in which they can share ideas by communicating with one another. Scholarly articles in the field of science are also uploaded weekly. It is important to note that although such elements of science are regularly updated on the website, a user should also work towards advancements in science in their spare time if they take the field of science quite seriously. Oncotarget is a website that allows people to use it as a way to support their very own works of advancements in science and is available on Impact Journals.
Not only is Oncotarget a viable option for advancing in science, it is also a wonderful site for one to improve their writing skills. One’s skills in writing can almost always use room for improvement. Although one may not necessarily be aware, there are many different elements of writing, many of which many writers do not necessarily even use, even the most proficient and prolific of them. By utilizing Oncotarget as much as possible, it’s highly recommended for you as a researcher and student to ensure that you’re taking necessary steps towards becoming a better writer, researcher, and observer simultaneously. All of these attributes in your learning can have effects of making you a better all around student. If you are unable to grasp certain elements of what is shown on the website, feel free to utilize the “Contact Us” page on the website as the representatives who are able to help may be able to provide you with some assistance that you may need to better understand what you may have concerns about. The aspect of the website in which it is updated weekly is something that makes the site worthwhile for anyone. View output styles at Endnote.com
Currently, Mikhail Blagosklonny is a professor of Oncology at Roswell Park Cancer Institute. Cancer has been seen to be the leading cause of death in all continents. This concept has attracted scientists from all walks of life to try and solve this problem by finding a cancer elusive treatment. As a scientist of Oncology, Mikhail Blagosklonny studies Cancer and Aging as he attempts to find a treatment for these two concepts. He has made numerous contributions towards finding an elusive treatment considering he is a specialist in treatment therapies and cancer biology. With his extensive research and academic background, Mikhail contributions in fighting cancer have some potential of being perfected to bring about cancer and aging treatment.
Career and Education Preview
Mr. Blagosklonny had the opportunity of studying at First Pavlov State Medical University based in St. Petersburg, Russia where he earned his MD in Internal Medicine and a Ph.D. in Cardiology and Experimental Medicine. With the help of his academic credentials, it was not hard for him to begin his career journey. In 2002, he joined the New York Medical College, Valhalla, New York as an associate professor. He later joined Ordway Research Institute as a research scientist. He continued to work in the firm as he wanted to gain the required experience. In 2009, he now joined Roswell Park Center to be a professor of Oncology a job he loves very much. He has been an excellent professor considering his experiences gained from working in different institutions. Some of his research interests include anti-aging and anticancer drugs, Biogerontology and therapies that protect healthy cells from being damaged.
Visit ResearchGate.Net to keep up to date with Mikhail’s latest work.
Mikhail Blagosklonny is responsible for authoring more than a hundred articles on the subjects of aging and cancer. He has also co-authored various research reviews and book chapters on both molecular and cellular biology of cancer cells considering their apoptosis, autophagy, and cycle. From his works cited he proposes the use of rapamycin, with the help of TOR signaling, to help in prolonging cell life in the human body. This is achieved through delaying autophagy, inhibiting apoptosis and promoting protein synthesis. He continues to argue that with the help of the TOR signaling regulation, cancer can be treated.
According to him, he believes it is possible to control aging and cancer, and he will one day be in a position of doing so. Check his LinkedIn profile to learn more.